Home › Ovarian Epithelial Carcinoma › Tennessee › Nashville
Ovarian Epithelial Carcinoma clinical trials in Nashville, TN
3 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
RecruitingPhase 3
- Sarah Cannon Research Institute (Oncology Associates of Oregon PC), Nashville
CT-95 in Advanced Cancers Associated With Mesothelin Expression
RecruitingPhase 1
- Context Investigational Site, Nashville
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
RecruitingPhase 1
- Vanderbilt University Medical Center, Nashville
Ovarian Epithelial Carcinoma trials in other cities
- Durham, NC8 studies
- Boston, MA8 studies
- San Diego, CA7 studies
- New York City, NY7 studies
- Chicago, IL7 studies
- Baltimore, MD6 studies
- Cleveland, OH6 studies
- Philadelphia, PA6 studies
- Houston, TX6 studies
- Minneapolis, MN5 studies
- Salt Lake City, UT5 studies
- Portland, OR5 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer81 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.